10-12 September 2018 //  Lancaster Royal Hotel, London

Sponsorship opportunities

Interested in positioning your brand in front of 400+ senior industry executives? Contact Ash Shirkhan now on
 +44 (0)20 7384 8239
 or on ash@phacilitate.co.uk , or fill out the form below.

Participants at Cell & Gene Therapy Europe are industry executives at Director level and above. Titles include:

  • Head of Global Medical Affairs & EU Clinical Development
  • VP & Head of Gene Therapy Development
  • SVP, Clinical & Regulatory
  • VP, Manufacturing
  • VP, Cell & Gene Therapy Product Development & Supply
  • Senior Director, Scientific Affairs & Analysis
  • Global Head of Clinical Development
  • Chief Executive Officer
  • Chief Medical Officer
  • Chief Regulatory & Compliance Officer


The remaining participants are high-level representatives of:

  • Key government bodies
  • NGOs
  • Analysts, VCs and other investors

Why People Come Back

Bluebird Bio

“Phacilitate gets better every year. In addition to providing an excellent forum to showcase the latest developments in regenerative medicine, it is one of the only forums where critical questions about how to successfully commercialize such innovative therapies are discussed.”

Faraz Ali, Vice President, Commercial Planning & External Affairs, Bluebird Bio  


 “Phacilitate are well known for having the market leading event for advanced therapies in the US, and now it seems you have the leading event in Europe too!”

Frank Hecht, Director Marketing & Sales, CellGenix

Enquire here


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad